Tag Archive for: Pharma

Optimum’s 17th Annual Healthcare Investor Conference 2025

DaltonTx raises £4 million seed financing to build the intelligence backbone of drug discovery

DaltonTx, a UK-based technology company, today announces its exit from from stealth and the completion of a £4 million seed financing round to build adaptive, AI-enabled discovery platforms that reshape the economics, timelines, and outcomes of R&D so breakthrough medicines reach patients faster. AI offers pharma a unique opportunity to discover medicines more effectively and […]

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil® (modafinil), and bring BRIUMVI® (ublituximab) to patients in Australia  Sydney, Australia and Düsseldorf, Germany – 22 July 2025 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on […]

Have we reached “peak drugs pricing”?

Challenges to pharma charging premium prices for branded drugs are not new.  Think of President Biden’s attempts to drive down prices with the Inflation Reduction Act. Or the UK’s strategy of capping the price the NHS pays for branded medicines with its VPAG rebate scheme.  But President Trump’s “most favoured nation” policy – which attempts […]

Will Trump hit foreign pharma companies with tariffs?

Well, the last fortnight’s certainly been a rollercoaster. Ever since President Trump announced his plans for sweeping tariffs on foreign goods entering the US on Thursday April 3, markets have hardly been able to catch their collective breath. First there was the initial shock, at which point stocks tanked, before lurching up and down, and […]

© Optimum Strategic Communications.